EF
RTO icon

Empowered Funds’s Rentokil RTO Stock Holding History

Empowered Funds’s Portfolio RTO Stock Details RTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-579
Closed -$14.7K – 1767
2024
Q4 		$14.7K Buy
+579
New +$14.7K ﹤0.01% 1649

Other funds holding RTO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
MC
MIG Capital Newport Beach, California $589M AUM 25.96% 1-Year Est. Return

Empowered Funds's RTO Position: Q1 2025 in Review

Empowered Funds sold out of Rentokil (RTO) in Q1 2025, closing a stake of 579 shares — an estimated $14.7K sold.

Empowered Funds first reported a position in RTO in Q4 2024 and held it in 1 quarter. The position peaked at $14.7K in Q4 2024. 209 funds tracked by Wall St. Rank hold RTO as of Q1 2025.

  • Empowered Funds reported no remaining Rentokil position as of Q1 2025 after selling out during the quarter.
  • Empowered Funds sold 579 Rentokil shares in Q1 2025, an estimated $14.7K.
  • Empowered Funds first reported a position in Rentokil in Q4 2024 and held it in 1 quarter.
  • Empowered Funds's Rentokil position peaked at $14.7K in Q4 2024.
  • 209 funds tracked by Wall St. Rank held Rentokil as of Q1 2025.

Based on Empowered Funds's 13F filing for Q1 2025, filed 16 May 2025.